Keywords
microbiota
vaginal disease
Lactobacillus
Lactobacillus crispatus
Lactobacillus gasseri
How to Cite
Abstract
Introduction. Cervical cancer (CC) is a preventable disease primarily caused by persistent infection with highrisk human papillomavirus (HPV). Molecular HPV testing and cervical cytology are key tools for screening. Objectives. Evaluate the prevalence of high-risk HPV infection in patients attended at Interzonal Doctor Diego Paroissien Hospital during 2024, using molecular testing based on the algorithm proposed by the Provincial Cancer Institute of Buenos Aires; identify the predominant genotypes and analyze the correlation between molecular and cytological findings. Materials and Methods. A descriptive, observational, and retrospective study. A total of 2260 samples were analyzed following the screening algorithm of the Provincial Cancer Institute. HPV testing was performed using real-time PCR (cobas® 4800). Results were correlated with available cytological reports and clinical variables. Results. Twelve percent of samples tested positive for high-risk HPV. Among these, 75.3% corresponded to non-16/18 oncogenic genotypes, 16.2% to HPV 16, and 5.9% to HPV 18. Only 115 HPV-positive samples included transformation zone epithelium. Cytological alterations were observed in 38 cases, including one epithelial cell carcinoma and six high-grade intraepithelial lesions. No significant differences were found between genotypes and epithelial damage (p=0.76) or associated microbiota (p=0.935). Conclusion. HPV molecular testing demonstrated high sensitivity for early detection of oncogenic infections, even before cytological alterations appear, supporting its use as the primary screening method. Improving cytological sampling quality is recommended. Continued monitoring of local genotype distribution is essential for adapting prevention and vaccination strategies.
References
1. Ma B, Forney LJ, Ravel J. Vaginal microbiome: rethinking health and disease. Annu Rev Microbiol. 2012;66:371-89. https://doi.org/10.1146/
annurev-micro-092611-150157
2. Gaziano R, Sabbatini S, Monari C. The Interplay between Candida albicans, Vaginal Mucosa, Host Immunity and Resident Microbiota in Health and Disease: An Overview and Future Perspectives. Microorganisms. 2023;11(5):1211. https://doi.org/10.3390/microorganisms11051211.
3. Muhleisen AL, Herbst-Kralovetz MM. Menopause and the vaginal microbiome. Maturitas. 2016;91:42-50. https://doi.org/10.1016/j
. maturitas.2016.05.015.
4. Santoro N, Roeca C, Peters BA, Neal-Perry G. The Menopause Transition: Signs, Symptoms, and Management Options. J Clin Endocrinol Metab. 2021;106(1):1-15. https://doi.org/10.1210/clinem/dgaa764
5. Wang J, Xu J, Han Q, Chu W, Lu G, Chan WY, et al. Changes in the vaginal microbiota associated with primary ovarian failure. BMC Microbiol. 2020;20(1):230. https://doi.org/10.1186/s12866-020-01918-0
6. Smith SB, Ravel J. The vaginal microbiota, host defence and reproductive physiology. J Physiol. 2017;595(2):451-63. https://doi.org/10.1113/JP271694
7. Wang Y, Liu Z, Chen T. Vaginal microbiota: Potential targets for vulvovaginal candidiasis infection. Heliyon. 2024;10(5):e27239. https://doi. org/10.1016/j.heliyon.2024.e27239
8. Nyirjesy P. Postmenopausal vaginitis. Curr Infect Dis Rep. 2007;9(6):480- 4. https://doi.org/10.1007/s11908-007-0073-5
9. Waetjen LE, Crawford SL, Gajer P, Brooks MM, Gold EB, Reed BD, et al. Relationships between the vaginal microbiota and genitourinary syndrome of menopause symptoms in postmenopausal women: the Study of Women’s Health Across the Nation. Menopause. 2023;30(11):1073-84. https://doi.org/10.1097/GME.0000000000002263
10. Baek JC, Jo HC, Lee SM, Park JE, Cho IA, Sung JH. Prevalence of Pathogens and Other Microorganisms in Premenopausal and Postmenopausal Women with Vulvovaginal Symptoms: A Retrospective Study in a Single Institute in South Korea. Medicina (Kaunas). 2021;57(6):577. https://doi. org/10.3390/medicina57060577
11. De Oliveira NS, de Lima ABF, de Brito JCR, Sarmento ACA, Gonçalves AKS, Eleutério J Jr. Postmenopausal Vaginal Microbiome and Microbiota. Front Reprod Health. 2022;3:780931. https://doi.org/10.3389/
frph.2021.780931
12. Proyecto BACOVA, Programa PROSAR, Fundación Bioquímica Argentina. Manual de Procedimientos BACOVA 2012. Disponible en: http://www.fba. org.ar/PROSAR
13. Poch F, Levin D, Levin S, Dan M. Modified thioglycolate medium: a simple and reliable means for detection of Trichomonas vaginalis. J Clin Microbiol. 1996;34(10):2630-1. https://doi.org/10.1128/jcm.34.10.2630-2631.1996
14. Perazzi BE, Menghi CI, Coppolillo EF, Gatta C, Eliseth MC, de Torres RA, et al. Prevalence and comparison of diagnostic methods for Trichomonas vaginalis infection in pregnant women in Argentina. Korean J Parasitol. 2010;48(1):61-5. https://doi.org/10.3347/kjp.2010.48.1.61
15. Nugent RP, Krohn MA, Hillier SL. Reliability of diagnosing bacterial vaginosis is improved by a standardized method of gram stain interpretation. J Clin Microbiol. 1991;29(2):297-301. https://doi.org/10.1128/jcm.29.2.297-301.1991
16. Jorgensen JH, Pfaller MA, Carrol KC, Funke G, Landry ML, Richter SS, Warnock DW, editors. Manual of Clinical Microbiology. 11th edition. Washington DC, ASM Press, 2015.
17. Karas M, Krüger R. Ion formation in MALDI: the cluster ionization mechanism. Chem Rev. 2003 ;103(2):427-40. https://doi.org/10.1021/cr010376a
18. Donders GG, Bosmans E, Dekeersmaecker A, Vereecken A, Van Bulck B, Spitz B. Pathogenesis of abnormal vaginal bacterial flora. Am J Obstet Gynecol. 2000;182(4):872-8. https://doi.org/10.1016/s0002-9378(00)70338-3
19. van de Wijgert JHHM. The vaginal microbiome and sexually transmitted infections are interlinked: Consequences for treatment and prevention. PLoS Med. 2017;14(12):e1002478. https://doi.org/10.1371/journal. pmed.1002478
20. Makwana, N., Shah, M., & Chaudhary, M. Vaginal pH as a Diagnostic Tool for Menopause: A Preliminary Analysis. Journal of mid-life health. 2020;11(3), 133–36. https://doi.org/10.4103/jmh.JMH_1_20
21. Mirmonsef P, Modur S, Burgad D, Gilbert D, Golub ET, French AL, et al. Exploratory comparison of vaginal glycogen and Lactobacillus levels in premenopausal and postmenopausal women. Menopause. 2015;22(7):702-9. https://doi.org/10.1097/GME.0000000000000397
22. Blackwell AL, Fox AR, Phillips I, Barlow D. Anaerobic vaginosis (nonspecific vaginitis): clinical, microbiological, and therapeutic findings. Lancet. 1983;2(8364):1379-82. https://doi.org/10.1016/s0140- 6736(83)90920-0
23. O’Dowd TC, West RR, Winterburn PJ, Hewlins MJ. Evaluación de una prueba diagnóstica rápida para la vaginosis bacteriana. Br J Obstet Gynaecol. 1996;103(4):366-70. https://doi.org/10.1111/j.1471-0528.1996.tb09743.x
24. da Silva Wanderley M, de Resende Miranda CR, Carneiro de Freitas MJ, Sousa Pessoa AR, Lauand A, Mafra Lima R. Bacterial vaginosis in menopausal women and in women with infertility. Rev. Bras. Ginecol. Obstet. 2001;23(10):80-6. https://doi.org/10.1590/S0100-
72032001001000005
25. Estevao Belchior S, Fosch S, Yones C, de Torres Puigarnau R, Palaoro L, et al. Estudio multicéntrico de disfunción vaginal de la Red Nacional de Laboratorios BACOVA de la República Argentina: Prevalencia, influencia de factores seleccionados, evaluación clínica y distribución de casos por región; Federación Bioquímica de la Provincia Buenos Aires; Acta Bioquímica Clínica Latinoamericana. 2021;55(Suppl. 1):1-48.https:// www.redalyc.org/journal/535/53570548004/
26. Farage M, Maibach H. Lifetime changes in the vulva and vagina. Arch Gynecol Obstet. 2006;273(4):195-202. https://doi.org/10.1007/s00404-005-0079-x
27. Coelingh Bennink HJ. Are all estrogens the same? Maturitas. 2004;47(4):269-75. https://doi.org/10.1016/j.maturitas.2003.11.009
28. Zhang R, Daroczy K, Xiao B, Yu L, Chen R, Liao Q. Qualitative and semiquantitative analysis of Lactobacillus species in the vaginas of healthy fertile and postmenopausal Chinese women. J Med Microbiol. 2012;61(Pt 5):729-39. https://doi.org/10.1099/jmm.0.038687-0
29. Gustafsson RJ, Ahrné S, Jeppsson B, Benoni C, Olsson C, Stjernquist M, Ohlsson B. The Lactobacillus flora in vagina and rectum of fertile and postmenopausal healthy Swedish women. BMC Womens Health. 2011;11(1):17. https://doi.org/10.1186/1472-6874-11-17
30. Perazzi B. E, Maldonado V, Losada M, Susuki V, Diaz Altuzarra M. D, Cocucci S, et al. Evaluación mediante los estados vaginales básicos de la disfunción vaginal según diferentes factores de riesgo y caracterización de la microbiota lactobacilar. Bioquímica y Patología Clínica [Internet]. 2018;82(1):57-71. https://www.redalyc.org/articulo.oa/id=65173031005
31. Edwards VL, Smith SB, McComb EJ, Tamarelle J, Ma B, Humphrys MS, et al. The Cervicovaginal Microbiota-Host Interaction Modulates Chlamydia trachomatis Infection. mBio. 2019;10(4):e01548-19. https://doi. org/10.1128/mBio.01548-19
32. Brotman RM, Shardell MD, Gajer P, Fadrosh D, Chang K, Silver MI, et al Association between the vaginal microbiota, menopause status, and signs of vulvovaginal atrophy. Menopause 2014;21:450-8. https://doi.org/10.1097/GME.0000000000001236 33. Parolin C, Croatti V, Giordani B, Vitali B. Vaginal Lactobacillus Impair Candida Dimorphic Switching and Biofilm Formation. Microorganisms. 2022;10(10):2091. https://doi.org/10.3390/microorganisms10102091
34. Song YL, Kato N, Matsumiya Y, Liu CX, Kato H, Watanabe K. Identification of and hydrogen peroxide production by fecal and vaginal lactobacilli isolated from Japanese women and newborn infants. J Clin Microbiol. 1999;37(9):3062-4. https://doi.org/10.1128/JCM.37.9.3062-3064.1999
35. Ravel J, Gajer P, Abdo Z, Schneider GM, Koenig SS, McCulle SL, et al. Vaginal microbiome of reproductive-age women. Proc Natl Acad Sci U S A. 2011;108 (Suppl 1):4680-7. https://doi.org/10.1073/pnas.1002611107
36. Ravel J, Brotman RM, Gajer P, Ma B, Nandy M, Fadrosh DW, et al. Daily temporal dynamics of vaginal microbiota before, during and after episodes of bacterial vaginosis. Microbiome. 2013;1(1):29. https://doi.org/10.1186/2049-2618-1-29
37. Van Gerwen OT, Smith SE, Muzny CA. Bacterial Vaginosis in Postmenopausal Women. Curr Infect Dis Rep. 2023;25(1):7-15. https://doi.org/10.1007/s11908-022-00794-1
38. Stewart LL, Vodstrcil LA, Coombe J, Bradshaw CS, Hocking JS. Prevalence of bacterial vaginosis in postmenopausal women: a systematic review and meta-analysis. Sex Health. 2022;19(1):17-26. https://doi.org/10.1071/SH21083
39. Donders G, Bellen G, Rezeberga D. Aerobic vaginitis in pregnancy. BJOG. 2011;118(10):1163-70. https://doi.org/10.1111/j.1471-0528.2011.03020.x
40. Donders GGG, Bellen G, Grinceviciene S, Ruban K, Vieira-Baptista P. Aerobic vaginitis: no longer a stranger. Res Microbiol. 2017;168(9-10):845-58. https://doi.org/10.1016/j.resmic.2017.04.004
41. Bruins MJ, Dos Santos CO, Damoiseaux RAMJ, Ruijs GJHM. Bacterial agents in vulvovaginitis and vaginal discharge: a 10-year retrospective study in the Netherlands. Eur J Clin Microbiol Infect Dis. 2021;40(10):2123-8. https://doi.org/10.1007/s10096-021-04265-8